Genetic background as a possible determinant of clinical and biological features of Epstein-Barr virus infection--a hypothetical view.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Critical reviews in oncology/hematology

• Publication date

  2002-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1040-8428(02)00113-0PMID 12467962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epstein-Barr virus BHRF1 gene but not the cellular protooncogenebcl-2 is expressed in ataxia-telangiectasia lymphoblastoid lines

  2004cited by this paper
• ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response.

  2001cited by this paper
• The ATM–Chk2–Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

  2001cited by this paper
• DNA double-strand breaks: signaling, repair and the cancer connection

  2001cited by this paper
• The many substrates and functions of ATM

  2000cited by this paper
• ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway

  2000cited by this paper
• ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes

  2000cited by this paper
• Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity.

  2000cited by this paper
• Epstein-Barr virus infection.

  2000cited by this paper
• Defective control of apoptosis and mitotic spindle checkpoint in heterozygous carriers of ATM mutations.

  1999cited by this paper
• Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia.

  1998cited by this paper
• Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms

  1997cited by this paper
• Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints.

  1997cited by this paper
• Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

  1997cited by this paper
• Atm-dependent interactions of a mammalian chk1 homolog with meiotic chromosomes.

  1997cited by this paper
• Interaction between ATM protein and c-Abl in response to DNA damage

  1997cited by this paper
• Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation

  1997cited by this paper
• The genetic defect in ataxia-telangiectasia.

  1997cited by this paper
• DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation.

  1997cited by this paper
• Defect in Multiple Cell Cycle Checkpoints in Ataxia-Telangiectasia Postirradiation*

  1996cited by this paper
• rad-Dependent Response of the chk1-Encoded Protein Kinase at the DNA Damage Checkpoint

  1996cited by this paper
• Ionizing radiation-induced phosphorylation of RPA p34 is deficient in ataxia telangiectasia and reduced in aged normal fibroblasts.

  1996cited by this paper
• A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

  1995cited by this paper
• The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species.

  1995cited by this paper
• The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.

  1994cited by this paper
• Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay.

  1994cited by this paper
• The ionizing radiation-induced replication protein A phosphorylation response differs between ataxia telangiectasia and normal human cells

  1993cited by this paper
• A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

  1992cited by this paper
• Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.

  1988cited by this paper
• Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.

  1985cited by this paper
• Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients

  1984cited by this paper

• Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan

  2009cites this paper
• The rate of extrachromosomal homologous recombination within a novel reporter plasmid is elevated in cells lacking functional ATM protein.

  2004cites this paper